Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alzai HealthFRA:H2F -1.62%9 OCF Yield % is -8.63 as of Aug. 08, 2026. GuruFocus rates FRA:H2F with a GF Score™ of 9/100. The stock has 1 warning sign investors should review. Among 1,410 Biotechnology companies, Alzai Health ranks worse than 50.28% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Alzai Health OCF Yield % Related Terms
Alzai Health OCF Yield % Historical Data
* Premium members only.
The historical data trend for Alzai Health's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alzai Health OCF Yield % Chart
Alzai Health Annual Data
Trend
Apr25
OCF Yield %
0.00
Alzai Health Quarterly Data
Jan25
Apr25
Jul25
Oct25
Jan26
OCF Yield %
0.00
0.00
0.00
0.00
0.00
FRA:H2F vs VRTX, REGN, RVMD: OCF Yield % Comparison
For the Biotechnology subindustry, Alzai Health's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alzai Health OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alzai Health's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Alzai Health's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alzai Health (FRA:H2F) has a OCF Yield % of -8.63 as of Aug. 08, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Alzai Health and its competitors. According to the industry distribution chart, Alzai Health ranks #709 out of 1410 companies in the Biotechnology industry, placing it in the top 50.3%.
Is Alzai Health's OCF Yield % too high?
Alzai Health's current OCF Yield % is -8.63. Based on the distribution chart, Alzai Health ranks #709 out of 1410 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Alzai Health has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Alzai Health's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Alzai Health ranks #709 out of 1410 companies for OCF Yield %. This places Alzai Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Alzai Health and its competitors. Alzai Health's current OCF Yield % is -8.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzai Health stock overvalued right now?
Alzai Health (FRA:H2F) has a current OCF Yield % of -8.63. The current OCF Yield % is -8.63. Alzai Health's overall GF Score™ is 9/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Alzai Health (FRA:H2F), the current OCF Yield % is -8.63 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alzai Health Corp is a healthcare company focused on comprehensive health solutions. It is an AI-driven Alzheimer's disease risk screening platform, enabling disease prevention and early disease diagnosis to improve patient outcomes. The company uses low-cost, non-invasive, pre-existing biomarker data present in nearly all Electronic Medical Records of the relevant age demographic. It aims to address the unmet need in Alzheimer's screening, enabling early detection and mitigation driving to diagnosis, therapy or prevention.
9GF Score
Get the complete analysis for FRA:H2F
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:H2F has been successfully added to your 
